» Articles » PMID: 31046858

Real-world Healthcare Utilization in Adult Congenital Heart Disease: a Systematic Review of Trends and Ratios

Overview
Journal Cardiol Young
Date 2019 May 4
PMID 31046858
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As a result of medical advances, the adult congenital heart disease population is rapidly expanding. Nonetheless, most patients remain prone to increased morbidity and mortality. Therefore, long-term medical resource use is required. This systematic review aims to present the trends over the past decades of medical resource utilization in adult congenital heart disease as well as its current status, with a focus on hospitalizations, emergency department visits, outpatient cardiology visits, and visits to other healthcare professionals.

Methods: MEDLINE (Pubmed), Embase, and Web of Science were searched for retrospective database research publications. The ISPOR checklist for retrospective database research was used for quality appraisal. Trends over time are explored.

Results: Twenty-one articles met the inclusion criteria. All but one of the studies was conducted in Western Europe and North America. The absolute number of hospitalizations has been increasing over the last several decades. This increase is highest in patients with mild lesions, although these numbers are largely driven by hospitalizations of patients with an atrial septal defect or a patent foramen ovale. Meanwhile, outpatient cardiology visits are increasing at an even higher pace, and occur most often in geriatric patients and patients with severe lesions. Conversely, the number of hospitalizations per 100 patients is decreasing over time. Literature is scarce on other types of healthcare use.

Conclusion: A strong rise in healthcare utilization is noticed, despite the mitigating effect of improved efficiency levels. As the population continues to grow, innovative medical management strategies will be required to accommodate its increasing healthcare utilization.

Citing Articles

Healthcare consumption in congenital heart disease: A temporal life-course perspective following pediatric cases to adulthood.

Pardhan S, Mandalenakis Z, Giang K, Fedchenko M, Eriksson P, Dellborg M Int J Cardiol Congenit Heart Dis. 2024; 11:100440.

PMID: 39713573 PMC: 11657615. DOI: 10.1016/j.ijcchd.2023.100440.


Incidence and Predictors of Stroke in Australian Adults With Congenital Heart Disease (2000-2017).

Sodhi-Berry N, Burchill L, Kleinig T, Nedkoff L, Katzenellenbogen J J Am Heart Assoc. 2024; 13(17):e034057.

PMID: 39190566 PMC: 11646527. DOI: 10.1161/JAHA.123.034057.


Blood Biomarkers Predict 10-Year Clinical Outcomes in Adult Patients With Congenital Heart Disease.

Hendriks P, van den Bosch A, Geenen L, Baggen V, Eindhoven J, Kauling R JACC Adv. 2024; 3(9):101130.

PMID: 39157753 PMC: 11327932. DOI: 10.1016/j.jacadv.2024.101130.


Outcomes following major thoracoabdominal cancer resection in adults with congenital heart disease.

Sakowitz S, Bakhtiyar S, Ali K, Mallick S, Williamson C, Benharash P PLoS One. 2024; 19(1):e0295767.

PMID: 38165963 PMC: 10760660. DOI: 10.1371/journal.pone.0295767.


Last year of life of adults with congenital heart diseases: causes of death and patterns of care.

Van Bulck L, Goossens E, Morin L, Luyckx K, Ombelet F, Willems R Eur Heart J. 2022; 43(42):4483-4492.

PMID: 36030410 PMC: 9637423. DOI: 10.1093/eurheartj/ehac484.